Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

Benefit from blood-pressure-lowering drugs is linked to urinary albumin level

Nature Clinical Practice Nephrology volume 4, pages 348–349 (2008)Cite this article

Boersma C et al. (2008) Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events. Br J Clin Pharmacol 65: 723–732

In an observational analysis of Dutch adults who participated in the community-based PREVEND trial, Boersma et al. have shown that hypertensive people with elevated urinary albumin levels receive a greater benefit from blood-pressure-lowering drugs, especially those that interfere with the renin–angiotensin system, than do individuals with normal urinary albumin levels.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benefit from blood-pressure-lowering drugs is linked to urinary albumin level. Nat Rev Nephrol 4, 348–349 (2008). https://doi.org/10.1038/ncpneph0836

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0836

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing